Jason Paik MD PhD
About Jason Paik MD PhD
Jason Paik MD PhD is the Senior Medical Director at BeiGene, specializing in the development of novel therapeutics for hematologic malignancies and gastrointestinal malignancies.
Current Role at BeiGene
Jason Paik, MD PhD, currently holds the position of Senior Medical Director at BeiGene. In this role, he is responsible for overseeing medical strategies and clinical development. His leadership includes spearheading significant clinical trials and guiding the development of novel therapeutics for various malignancies. One notable project he leads is the clinical trial BGB-16673-101, a Phase 1/2 study of a BTK degrader.
Professional Experience at BeiGene
Jason Paik's tenure at BeiGene spans several key roles. Initially joining as an Associate Medical Director (2020-2021), he then advanced to the role of Medical Director (2021-2024) before assuming his current position as Senior Medical Director. His work at BeiGene has been marked by significant contributions to the clinical development of novel therapeutics for hematologic malignancies, showcasing his deep expertise in cancer treatment and research.
Previous Positions at Stanford Health Care
Before his tenure at BeiGene, Jason Paik built a strong foundation in clinical expertise through his work at Stanford Health Care. He spent five years (2013-2018) as a Fellow in Hematology & Oncology, preceded by two years (2011-2013) as an Intern & Resident in Internal Medicine. These roles at Stanford enabled him to gain extensive experience in the clinical management of gastrointestinal malignancies and other cancer-related conditions.
Educational Background
Jason Paik has a robust academic background in the field of cancer biology. He earned an MD/PhD from the University of Alabama at Birmingham (2002-2011), where he focused on Cancer Biology. Prior to this, he completed his undergraduate studies at Washington University in St. Louis (1998-2002), achieving a BA in Biochemistry and Molecular Biology. This educational foundation has equipped him with a comprehensive understanding of both the clinical and research aspects of cancer treatment.
Specializations and Expertise
Jason Paik specializes in the development of novel therapeutics for hematologic malignancies. His expertise covers a broad spectrum, including the clinical management of gastrointestinal malignancies and the research and development of cancer treatments. His diverse experience and strong background in cancer biology make him a key figure in advancing therapeutic options in oncology.